Park, Hanjin
Kim, Daehoon
Jang, Eunsun
Yu, Hee Tae
Kim, Tae-Hoon
Kim, Dong-min
Sung, Jung-Hoon
Pak, Hui-Nam
Lee, Moon-Hyoung
Lip, Gregory Y. H.
Yang, Pil-Sung
Joung, Boyoung http://orcid.org/0000-0001-9036-7225
Funding for this research was provided by:
Ministry of Health & Welfare, Republic of Korea (HC19C0130)
Article History
Received: 25 September 2023
Accepted: 22 April 2024
First Online: 13 May 2024
Declarations
:
: This study was approved by the Institutional Review Board of the Yonsei University Health System (2023-0659-001). The requirement for informed consent was waived because personally identifying information was removed after cohort generation, in accordance with strict confidentiality guidelines.
: Not applicable.
: Boyoung Joung has served as a speaker for Bayer, BMS/Pfizer, Medtronic, and Daiichi-Sankyo and received research funds from Medtronic and Abbott. Gregory Lip has been a consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, and Anthem. No fees were received personally. The remaining authors have no conflicts to declare.